Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE has floated a tender for Antibacterial Agents for Systemic Use Xxvii. - Clindamycin, Metronidazole, Ofloxacin, Rifaximin. The project location is Czech Republic and the tender is closing on 09 Apr 2024. The tender notice number is 142872-2024, while the TOT Ref Number is 98404126. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Czech Republic
Summary : Antibacterial Agents for Systemic Use Xxvii. - Clindamycin, Metronidazole, Ofloxacin, Rifaximin
Deadline : 09 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 98404126
Document Ref. No. : 142872-2024
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : CZK 7998000
Purchaser's Detail
Purchaser : INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE
Address: Videňska 1958
Town: Praha
NUTS-Code: CZ010
Postal Code: 14000
Phone: 420 261365064
Czech Republic
Email :monika.siskova@ikem.cz
URL :https://www.ikem.cz
Tender Details
The subject of the public contract is the regular supply of medicinal products for oral use containing the active substances Clindamycin (ATC J01FF01), Metronidazole (P01AB01), Ofloxacin (ATC J01MA01) and Rifaximin (ATC A07AA11) for the treatment of patients in approved indications according to the SPC valid on the date of submission of the offer.
1. part - CLINDAMYCIN
The subject of the public contract is the regular supply of medicinal products for oral use containing the active substance Clindamycin (ATC J01FF01) for the treatment of patients in approved indications according to the SPC valid on the date of submission of the offer.
2. part - METRONIDAZOLE
Subject to public procurementare regular supplies of medicinal products for oral use containing the active substance Metronidazole (P01AB01) for the treatment of patients in approved indications according to the SPC valid on the date of submission of the offer.
3. part - OFLOXACIN
The subject of the public contract is the regular supply of medicinal products for oral useuse containing the active substance Ofloxacin (ATC J01MA01) for the treatment of patients in approved indications according to the SPC valid on the date of submission of the offer.
Part 4 - RIFAXIMIN
The subject of the public contract is the regular supply of medicinal products for oral use containing the active ingredient Rifaximin (ATC A07AA11)for the treatment of patients in approved indications according to the SPC valid on the date of submission of the offer.
Doc Title: Antibacterial substances for systemic use XXVII. - Clindamycin, Metronidazole, Ofloxacin, Rifaximin
Contract Type: supplies
Document Type: Contract Notice
Reference Number: PZ-2024-0000325
Contract Type: supplies
Estimated Value: 7998000 - CZK
Authority Type: pub-undert-cga
Doc Title: Antibacterial substances for systemic use XXVII. - Clindamycin, Metronidazole, Ofloxacin, Rifaximin
Dispatch Date: 2024-03-07
Publish Datee: 2024-03-08
Submission Date: 2024-04-09
Documents
Want To Bid in This Tender?
Get Local Agent Support in Czech Republic and 60 More Countries.
View Tenders By
Sign in with Google